Wearable Heart Mapping May Help Identify Cardiovascular Hospitalization Risk
Posted on 19 Nov 2026
Cardiac scar tissue can develop when heart muscle cells die and fail to regenerate, often due to vascular blockages or age-related changes, even in individuals without a history of heart attack. This scarring can disrupt the heart’s electrical activity and increase the risk of cardiovascular hospitalization. To better identify these risks, researchers have investigated whether a wearable vest that maps cardiac electrical activity can detect abnormalities associated with heart scarring.
Researchers at University College London (UCL) developed an electrocardiographic imaging (ECGI) vest designed to map the heart’s electrical activity in greater detail than conventional electrocardiography. The reusable vest contains 256 integrated electrodes and can be washed or disinfected between uses. Within approximately five minutes, it generates a detailed, color-coded map showing the timing, strength, and movement of electrical signals across the heart.
Unlike a conventional electrocardiogram, which uses 10 electrodes placed on the chest, arms, and legs, the ECGI vest provides more detailed localization of electrical abnormalities. To investigate their relationship with cardiac scarring, researchers compared the vest’s electrical measurements with magnetic resonance imaging (MRI) findings. Electrode positions were marked on participants’ chests using MRI-visible stickers, allowing the team to match areas of disrupted electrical activity with regions of scar tissue identified on imaging.
The study included 402 older adults with an average age of 76, all of whom underwent ECGI vest assessment and cardiac MRI. Approximately 70% of participants had evidence of cardiac scarring, including individuals without a previous heart attack. Even relatively minor scarring was associated with changes in the heart’s electrical activity, suggesting that age-related tissue damage may affect cardiac conduction before more obvious clinical problems emerge.
Participants with greater cardiac scarring generally had worse electrical activity scores. In particular, abnormalities in the electrical signals associated with the heart’s relaxation between beats were linked to an increased risk of cardiovascular hospitalization. Each one-point increase in the disruption score was associated with a 9% higher likelihood of hospitalization over an average follow-up of 13 months. Hospitalizations involved conditions such as heart attack, stroke, heart failure, and atrial fibrillation. However, only 26 participants experienced cardiovascular hospitalization, and researchers emphasized the need for larger studies to confirm the findings and evaluate the technology’s potential for identifying patients at increased cardiovascular risk.
The volunteers were born in 1946 and are part of the Medical Research Council’s National Survey of Health and Development. The ECGI vest was developed in 2019 and has previously been used to map hearts affected by hypertrophic cardiomyopathy and dilated cardiomyopathy.
“When we judge the risk to our hearts as we get older, we often think about blood pressure and stiffening arteries. But this study suggests the scar tissue found in our hearts is important to look at too. Our vest gives a more detailed picture of the scar tissue and the damage it could cause to the electrical workings of the heart. That could help us identify older people at greater risk, who need to be monitored more closely, and those who can be reassured their scar tissue is less likely to cause a problem,” said Gaby Captur, professor of cardiology at UCL and consultant cardiologist.
Related Links
University College London